Quanterix Corp.
(NASDAQ : QTRX)

( )
QTRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-1.00%129.470.7%$932.96m
PFEPfizer Inc.
-0.24%36.820.9%$753.37m
MRKMerck & Co., Inc.
-0.75%81.990.7%$609.53m
ABBVAbbVie, Inc.
0.11%70.592.3%$551.76m
BMYBristol-Myers Squibb Company
0.06%49.461.4%$446.52m
LLYEli Lilly and Company
-0.69%110.121.0%$338.32m
AZNAstraZeneca PLC Sponsored ADR
-0.59%42.521.2%$133.35m
NVSNovartis AG Sponsored ADR
-0.97%86.150.2%$128.28m
GSKGlaxoSmithKline plc Sponsored ADR
-0.69%40.610.3%$81.86m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.06%49.470.1%$67.96m
SNYSanofi Sponsored ADR
-0.25%43.600.2%$51.03m
LCILannett Company, Inc.
-3.66%13.4435.6%$48.84m
AKTXAkari Therapeutics Plc Sponsored ADR
3.67%1.981.6%$2.51m
EPIXESSA Pharma Inc
-1.64%3.000.1%$0.18m

Company Profile

Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Lexington, MA.